CYP2C19 and Nongenetic Factors Predict Poor Responsiveness to Clopidogrel Loading dose after Coronary Stent Implantation
-
- Tobias Geisler
- Department of Cardiology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, Tuebingen, Germany. Tel.: Fax:
-
- Elke Schaeffeler
- Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Auerbachstrasse 112 Germany. Tel.: Fax:
-
- Juergen Dippon
- Department of Mathematics, University of Stuttgart, Stuttgart, Germany
-
- Stefan Winter
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
-
- Verena Buse
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
-
- Christian Bischofs
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
-
- Christine Zuern
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
-
- Klaus Moerike
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
-
- Meinrad Gawaz
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
-
- Matthias Schwab
- Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany
Journal
-
- Pharmacogenomics
-
Pharmacogenomics 9 (9), 1251-1259, 2008-09
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1362825893735147520
-
- ISSN
- 17448042
- 14622416
-
- Data Source
-
- Crossref